drugset / Trial / NCT00209404

Iodixanol in Multidetector-Row Computed Tomography-Coronary Angiography (MDCT-CA)

NCT00209404

Phase 4 Completed 50 enrolled GE Healthcare
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

Image quality in coronary artery computed tomography is influenced by the heart rate variation during the examination. The purpose of this clinical trial is to investigate the change in heart rate following injection of a contrast medium called Visipaque™ (iodixanol). Image quality and diagnostic quality of the examination will be evaluated.

Timeline

Start
2005-07
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Iodixanol Diagnostic / imaging agent 320 mg/ml